Company
Verva
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Developed a novel insulin sensitiser for type 2 diabetes with an improved safety profile over TZDs.
Loading relationship preview
Company
Record updated 28 September 2026
Developed a novel insulin sensitiser for type 2 diabetes with an improved safety profile over TZDs.
VC Catalog has relationship data for this record. Sign in with Google to explore it on the interactive map.